Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Hematopoietic Growth Factors in Transfusion Medicine and Cellular Therapy - Part II.

Schlenke P, Humpe A.

Transfus Med Hemother. 2013 Oct;40(5):300-1. doi: 10.1159/000354964. No abstract available.

PMID:
24273482
[PubMed]
Free PMC Article
2.

Hematopoietic growth factors in transfusion medicine and cellular therapy - part I.

Schlenke P, Humpe A.

Transfus Med Hemother. 2013 Aug;40(4):223-4. doi: 10.1159/000354392. No abstract available.

PMID:
24179470
[PubMed]
Free PMC Article
3.

Clinical perspectives of mesenchymal stem cells.

Kramer J, Dazzi F, Dominici M, Schlenke P, Wagner W.

Stem Cells Int. 2012;2012:684827. doi: 10.1155/2012/684827. Epub 2012 Dec 24. No abstract available.

PMID:
23319960
[PubMed]
Free PMC Article
4.

Retrospective Analysis of the Blood Component Utilization in a University Hospital of Maximum Medical Care.

Geißler RG, Franz D, Buddendick H, Krakowitzky P, Bunzemeier H, Roeder N, Van Aken H, Kessler T, Berdel W, Sibrowski W, Schlenke P.

Transfus Med Hemother. 2012 Apr;39(2):129-138. Epub 2012 Mar 22.

PMID:
22670131
[PubMed]
Free PMC Article
5.

Massive Bleeding and Massive Transfusion.

Meißner A, Schlenke P.

Transfus Med Hemother. 2012 Apr;39(2):73-84. Epub 2012 Mar 12.

PMID:
22670125
[PubMed]
Free PMC Article
6.

Patient Blood Management: Clinical Hemotherapy and Hemostasis Management in Perioperative Settings.

Görlinger K, Schlenke P.

Transfus Med Hemother. 2012 Apr;39(2):57-58. No abstract available.

PMID:
22670122
[PubMed]
Free PMC Article
7.

Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Lindner U, Kramer J, Rohwedel J, Schlenke P.

Transfus Med Hemother. 2010 Apr;37(2):75-83. Epub 2010 Mar 15.

PMID:
20737049
[PubMed]
Free PMC Article
8.

Safeguards in Blood Supply: A National and European Challenge.

Frey BM, Schlenke P.

Transfus Med Hemother. 2010 Jun;37(3):109-110. No abstract available.

PMID:
20737015
[PubMed]
Free PMC Article
9.

As for the Past, as for 2010.

Schlenke P, Sibrowski W.

Transfus Med Hemother. 2010 Feb;37(1):5-6. No abstract available.

PMID:
20737010
[PubMed]
Free PMC Article
10.

Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.

Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H; Study Alliance Leukemia.

Blood. 2010 Nov 4;116(18):3564-71. doi: 10.1182/blood-2009-09-240978. Epub 2010 May 24.

PMID:
20498303
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Murine mesenchymal progenitor cells from different tissues differentiated via mesenchymal microspheres into the mesodermal direction.

Böhrnsen F, Lindner U, Meier M, Gadallah A, Schlenke P, Lehnert H, Rohwedel J, Kramer J.

BMC Cell Biol. 2009 Dec 19;10:92. doi: 10.1186/1471-2121-10-92.

PMID:
20021685
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cross-Sectional Guidelines: Cutting Edge in Scientific Evidence and Practical Guidance.

Schlenke P, Sibrowski W.

Transfus Med Hemother. 2009;36(6):351. No abstract available.

PMID:
21245965
[PubMed]
Free PMC Article
13.

Construction and characterization of stably transfected BHK-21 cells with human-type sialylation characteristic.

Schlenke P, Grabenhorst E, Nimtz M, Conradt HS.

Cytotechnology. 1999 Jul;30(1-3):17-25. doi: 10.1023/A:1008049603947.

PMID:
19003352
[PubMed]
Free PMC Article
14.

The Impact of the German Tissue Act on the Manufacturing of Autologous and Allogeneic Stem Cell Preparations.

Schlenke P, Tapernon K, Ahlke C, Mertens A, Sibrowski W.

Transfus Med Hemother. 2008;35(6):446-452. Epub 2008 Nov 14.

PMID:
21512651
[PubMed]
Free PMC Article
15.

Antigen-induced B cell apoptosis is independent of complement C4.

Faust KB, Finke D, Klempt-Giessing K, Randers K, Zachrau B, Schlenke P, Kirchner H, Goerg S.

Clin Exp Immunol. 2007 Oct;150(1):132-9. Epub 2007 Jul 23.

PMID:
17645767
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A hexanucleotide selected for increased cellular uptake in cis contains a highly active CpG-motif in human B cells and primary peripheral blood mononuclear cells.

Mende M, Hopert A, Wünsche W, Overhoff M, Detzer A, Börngen K, Schlenke P, Kirchner H, Sczakiel G.

Immunology. 2007 Feb;120(2):261-72. Epub 2006 Nov 27.

PMID:
17137465
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.

Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs WJ.

J Clin Microbiol. 2003 Dec;41(12):5419-28.

PMID:
14662920
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of a novel mononuclear cell isolation procedure for serological HLA typing.

Schlenke P, Klüter H, Müller-Steinhardt M, Hammers HJ, Borchert K, Bein G.

Clin Diagn Lab Immunol. 1998 Nov;5(6):808-13.

PMID:
9801339
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.

Frohn C, Schlenke P, Kirchner H.

Immunology. 1997 Dec;92(4):567-70.

PMID:
9497500
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk